By Meghana Keshavan
May 1, 2026
Biotech Correspondent
Meghana Keshavan
meghana.keshavan@statnews.com
Vinay Prasad's acting replacement, remembering genomics pioneer J. Craig Venter, and more biotech news from The Readout
By Meghana Keshavan
May 1, 2026
Biotech Correspondent
Meghana Keshavan
meghana.keshavan@statnews.com

Alzheimer's drug rollout letdown, a China-based heart drug startup, and more biotech news from The Readout

Diamantas takes the reins, Regenxbio stakes claim in Duchenne gene therapy, and more biotech news from The Readout

UniQure will submit Huntington's therapy for approval, Eli Lilly buys 4E Therapeutics, and more biotech news

With a new patent settlement, Axsome Therapeutics can lower its sword against prospective generics makers taking aim at its…

David Chang will leave his post after an eight-year run at the cell therapy maker. Elsewhere, a next-generation blood disease…

AbbVie buys Apogee Therapeutics, LSD therapy Phase 3 results, and more biotech news from The Readout